It is reported that LYPD6B is expressed in the testes, prostate, stomach, lung, and glutamatergic neurons (89, 93) and that LYPD6B modulates specific nicotinic acetylcholine receptors (94); upregulated levels of LYPD6B have been associated with ovarian cancer (95). The gene discussed is LYPD6B; the disease is ovarian carcinoma.